ad image

API Manufacturing

1 / 1
Olon
M&A

Olon Continues its Growth Path and Announces a New Acquistion

Olon

PR-09-24-NI-01Sep 04, 2024
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
Outsourced Manufacturing

A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing

April Stanley, MS MBA

Nice Insight

PAO-03-24-NI-02Mar 27, 2024
Olon
High Potency API Suite

Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US

Olon

PR-M02-24-01Feb 05, 2024
Enhanced Solubility through API Processing: Salt and Cocrystal Formation
API

Enhanced Solubility through API Processing: Salt and Cocrystal Formation

Thomas Briel, Ph.D.; David Luedeker, Ph.D.

MilliporeSigma

PAO-05-23-CL-04May 05, 2023
Olon

Olon, International API Supplier, Releases New 2022 Sustainability Report

Olon

PR-M11-22-08Nov 22, 2022
Piramal Pharma Solutions
New Facility

Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site

Piramal Pharma Solutions

PR-M07-22-04Jul 13, 2022
The Evolving Technology Supporting API Manufacturing
Manufacturing

The Evolving Technology Supporting API Manufacturing

Pharma's Almanac

PAO-04-22-R250-76May 03, 2022
Looking at the Future of U.S. API Manufacturing
Specialty Chemicals

Looking at the Future of U.S. API Manufacturing

Brian Graves

W.R. Grace

PAO-04-22-R250-02Apr 01, 2022
Keeping Pharma Manufacturing Alive in Italy during COVID-19
Italian CDMOs

Keeping Pharma Manufacturing Alive in Italy during COVID-19

Nice Insight

PAO-04-22-R221-64Apr 29, 2021
Piramal Pharma Ltd.
API Manufacturing

Piramal Pharma Solutions Invests $25 Million CAD to Expand its Aurora, Canada Facility with a State-of-the-Art API Manufacturing Wing

Piramal Pharma Ltd.

PR-M01-20-NI-038Jan 28, 2020
Grifols
FDA Approval

Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins

Grifols

PR-M08-18-NI-123Aug 16, 2018
Cambrex
API Manufacturing

Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

Cambrex

PR-M07-18-NI-082Jul 25, 2018
BIOVECTRA
API Manufacturing

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion

BIOVECTRA

PR-M12-17-NI-013Dec 15, 2017
Harmonizing Development Internationally
Drug Development

Harmonizing Development Internationally

Trishul Shah

PolyPeptide Group

PTV-M06-17-BIO-012Aug 23, 2017
1 / 1